About: pancreatic ductal adenocarcinoma

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: pancreatic ductal adenocarcinoma Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

pancreatic adenocarcinoma that derives from pancreatic duct cells

Attributes	Values
rdf:type	Item
description	Krankheit (de) مرض يصيب الإنسان (ar) хвороба (uk) pancreatic adenocarcinoma that derives from pancreatic duct cells (en)
exact match	wds:Q18555956-19F21C65-1296-41CB-92AA-179C20ADD886 wds:Q18555956-F9CE60A6-6A15-4CA7-AB8C-0ACABBC2D2EA
exact match	http://purl.obolibrary.org/obo/DOID_3498 http://identifiers.org/doid/DOID:3498
Experimental Factor Ontology ID	wds:Q18555956-9DF06690-35A1-465E-912B-708A7BBD7EBD
Disease Ontology ID	wds:Q18555956-86E22A5A-23D7-4082-AFDC-6DD8D85825A5
Disease Ontology ID	http://purl.obolibrary.org/obo/DOID_DOID:3498
Experimental Factor Ontology ID	0002517
Disease Ontology ID	DOID:3498
rdfs:label	pancreatic ductal adenocarcinoma (en)
skos:prefLabel	pancreatic ductal adenocarcinoma (en)
name	pancreatic ductal adenocarcinoma (en)
instance of	wds:Q18555956-04A30AB8-5D03-4652-9B60-F2DB4E997287
instance of	class of disease
subclass of	wds:Q18555956-9E0C6068-DF20-49E5-B434-F80AF786D90C
subclass of	pancreatic adenocarcinoma
anatomical location	wds:Q18555956-13337322-C5A8-441F-9615-246C9AD17FCE
anatomical location	pancreatic duct
skos:altLabel	ductal adenocarcinoma of the pancreas (en)
NCI Thesaurus ID	wds:Q18555956-FBB782C6-9FF4-46B8-A04C-AE6B39D2AFD6
UMLS CUI	wds:Q18555956-1B884DE1-9617-4C8F-9D04-88ACA661FB21
on focus list of Wikimedia project	wds:Q18555956-0DA5E5EE-61FF-481B-A426-63F36D0CC8D0
NCI Thesaurus ID	C9120
UMLS CUI	C1335302
on focus list of Wikimedia project	WikiProject Medicine
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q18555956
is subclass of of	mixed ductal-endocrine carcinoma osteoclast-like giant cell neoplasm of the pancreas pancreatic signet ring cell adenocarcinoma
is subclass of of	wds:Q18557713-347F434F-025E-46B3-9325-D08A250A93A6 wds:Q18555954-FFEB48DC-7D46-4598-B2E0-FBACE156E3B8 wds:Q18557711-82D48A2F-98CC-4181-B8F1-2A8F5A6DA2C8
is main subject of	Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS). K-ras oncogene subtype mutations are associated with survival but not expression of p53, p16(INK4A), p21(WAF-1), cyclin D1, erbB-2 and erbB-3 in resected pancreatic ductal adenocarcinoma Development and histopathological characterization of tumorgraft models of pancreatic ductal adenocarcinoma Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma American gastroenterological association medical position statement: epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications. Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group. Molecular characteristics of pancreatic ductal adenocarcinoma Pancreatic ductal adenocarcinoma: diagnosis and staging with dynamic CT. DNA Aptamer Selected against Pancreatic Ductal Adenocarcinoma for in vivo Imaging and Clinical Tissue Recognition Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Loss of heterozygosity status of D9S105 marker is associated with downregulation of Krüppel-like factor 4 expression in pancreatic ductal adenocarcinoma and pancreatic intraepithelial lesions Differential roles of Smad2 and Smad3 in the regulation of TGF-β1-mediated growth inhibition and cell migration in pancreatic ductal adenocarcinoma cells: control by Rac1. Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma Staging of pancreatic ductal adenocarcinoma with spiral CT and MRI. Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo. Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma The autophagy inhibitor verteporfin moderately enhances the antitumor activity of gemcitabine in a pancreatic ductal adenocarcinoma model Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis. Pancreatic ductal adenocarcinoma: From genetics to biology to radiobiology to oncoimmunology and all the way back to the clinic Melatonin overcomes gemcitabine resistance in pancreatic ductal adenocarcinoma by abrogating nuclear factor-κB activation. PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47 Class III beta-tubulin, a marker of resistance to paclitaxel, is overexpressed in pancreatic ductal adenocarcinoma and intraepithelial neoplasia Distribution of extracellular matrix proteins in pancreatic ductal adenocarcinoma and its influence on tumor cell proliferation in vitro. A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. MicroRNA-10b expression correlates with response to neoadjuvant therapy and survival in pancreatic ductal adenocarcinoma Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma Restoration of E-cadherin expression in pancreatic ductal adenocarcinoma treated with microRNA-101. miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells. Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarcinoma Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma A high-fat diet activates oncogenic Kras and COX2 to induce development of pancreatic ductal adenocarcinoma in mice Inhibition of gamma-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma Chronic Pancreatitis Is Essential for Induction of Pancreatic Ductal Adenocarcinoma by K-Ras Oncogenes in Adult Mice Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software